
Medicare has a laudable goal to bargain for lower prices, but there’s a chance patients could lose out on billions in savings.

Sue Peschin, MHS, serves as President & CEO of the Alliance for Aging Research in Washington, D.C.

Medicare has a laudable goal to bargain for lower prices, but there’s a chance patients could lose out on billions in savings.

Medicare’s restrictive coverage policies are denying patients with early Alzheimer’s disease access to novel treatments. And private payers are following suit.